Cargando…
Serum IGFBP-2 and Risk of Atypical Hyperplasia of the Breast
Atypical hyperplasia of the breast (AH) is associated with increased risk of subsequent invasive breast cancer, yet little is known about the etiology of AH. Insulin-like growth factor binding protein 2 (IGFBP-2) may contribute to the development of AH due to its proliferative effects on mammary tis...
Autores principales: | Catsburg, Chelsea, Gunter, Marc J., Tinker, Lesley, Chlebowski, Rowan T., Pollak, Michael, Strickler, Howard D., Cote, Michele L., Page, David L., Rohan, Thomas E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464590/ https://www.ncbi.nlm.nih.gov/pubmed/26106415 http://dx.doi.org/10.1155/2015/203284 |
Ejemplares similares
-
Diabetes and Lung Cancer Among Postmenopausal Women
por: Luo, Juhua, et al.
Publicado: (2012) -
Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis
por: Guiot, J., et al.
Publicado: (2016) -
Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013) -
Vitamin D and breast cancer: interpreting current evidence
por: Chlebowski, Rowan T
Publicado: (2011) -
Postmenopausal Fracture History and Survival After Reproductive Cancer Diagnosis
por: Newcomb, Polly A, et al.
Publicado: (2018)